Related Experiment Video
Updated: Jun 23, 2026
07:59
Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Management of chronic stable angina pectoris
Luis Rodríguez-Ospina1, Luarde Montano-Soto
1Cardiology Section, Department of Medicine, Veterans Administration Caribbean Healthcare System, San Juan, Puerto Rico, USA. Luis.rodriguez-ospina@va.gov
Boletin De La Asociacion Medica De Puerto Rico
|April 30, 2009
Summary
This review details medical treatments for chronic stable angina, focusing on new drug strategies to improve quality of life and reduce cardiovascular events. It outlines a stepwise approach to medication management for angina relief.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Angina pectoris, chest discomfort from myocardial ischemia, often stems from narrowed coronary arteries.
- Atherosclerosis restricts oxygen supply to the heart during increased demand.
Purpose of the Study:
- To review current medical treatments for chronic stable angina.
- To highlight new medications and strategies for managing angina.
- To improve patient quality of life and reduce cardiovascular events and mortality.
Main Methods:
- Literature review focusing on medical management of chronic stable angina.
- Exclusion of revascularization techniques from the scope.
- Emphasis on pharmacological interventions and enhanced external counterpulsation.
Main Results:
- Reversible causes of angina (anemia, hypertension, etc.) must be addressed.
- Sublingual nitroglycerin provides immediate symptom relief.
- Aspirin (ASA) or clopidogrel, beta-blockers, and nitrates are foundational therapies.
- Dihydropyridine calcium channel blockers, ACE inhibitors (for specific patient groups), and ranolazine are subsequent treatment options.
- Enhanced external counterpulsation is considered for refractory cases.
Conclusions:
- A stepwise pharmacological approach can effectively manage chronic stable angina.
- Treatment aims to alleviate symptoms, enhance quality of life, and lower cardiovascular risk.
- Personalized medication selection based on patient comorbidities is crucial for optimal outcomes.
Related Concept Videos
01:26Angina IV: Management
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
01:20Angina V: Nursing Management
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
01:27Angina II: Classification
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
01:29Angina III: Clinical Manifestations and Assessment
Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...